Service d'Hépatologie et de Soins Intensifs Digestifs, Hôpital Jean Minjoz, Besançon cedex, France.
Liver Int. 2011 Mar;31(3):425-33. doi: 10.1111/j.1478-3231.2010.02431.x. Epub 2011 Jan 13.
Because over 90% of serum cortisol is bound to albumin and corticosteroid-binding globulin (CBG), changes in these proteins can affect measures of serum total cortisol levels in cirrhotics without altering serum-free and salivary cortisol concentrations.
We assessed basal (T₀) and post-synacthen (T₆₀) serum total cortisol, serum-free and salivary cortisol in 125 consecutive cirrhotics (95 non-septic and 30 septic patients with a Child>8).
Serum total cortisol levels significantly decreased from the Child A-C non-septic group, as did albumin and CBG levels, with a non-significant rise in serum-free cortisol concentrations. Non-septic patients with low albumin (≤25 g/L) or CBG levels (≤35 mg/L) had lower T₀ serum total cortisol levels than patients with near-normal albumin (303.4 vs. 382.6 nmol/L; P=0.0035) or with normal CBG levels (289.9 vs. 441.4 nmol/L; P<0.0001), respectively, despite similar serum-free cortisol or salivary cortisol concentrations. Subnormal T₆₀ serum total cortisol concentrations (<510.4 nmol/L) were measured in 7.2% of all patients (Child C: 14.5% vs. Child A and B: 0%; P=0.0013) but no patients exhibited symptoms suggesting adrenal insufficiency. Patients with or without subnormal T₆₀ total cortisol had similar T₀ salivary cortisol and serum-free cortisol concentrations. A trend was observed towards high serum-free cortisol concentrations and mortality in multivariate analysis.
Serum total cortisol levels overestimated the prevalence of adrenal dysfunction in cirrhotics with end-stage liver disease. Since serum-free cortisol cannot be measured routinely, salivary cortisol testing could represent a useful approach but needs to be standardized.
由于超过 90%的血清皮质醇与白蛋白和皮质类固醇结合球蛋白(CBG)结合,这些蛋白的变化可能会影响肝硬化患者血清总皮质醇水平的测量,而不会改变血清游离皮质醇和唾液皮质醇浓度。
我们评估了 125 例连续肝硬化患者的基础(T₀)和促肾上腺皮质激素后(T₆₀)血清总皮质醇、血清游离皮质醇和唾液皮质醇,其中 95 例非脓毒症患者和 30 例脓毒症患者(Child>8)。
血清总皮质醇水平从 Child A-C 非脓毒症组显著下降,白蛋白和 CBG 水平也下降,血清游离皮质醇浓度略有升高。白蛋白(≤25g/L)或 CBG 水平(≤35mg/L)低的非脓毒症患者的 T₀ 血清总皮质醇水平低于白蛋白接近正常(303.4 与 382.6nmol/L;P=0.0035)或 CBG 水平正常(289.9 与 441.4nmol/L;P<0.0001)的患者,尽管血清游离皮质醇或唾液皮质醇浓度相似。所有患者中有 7.2%(Child C:14.5%比 Child A 和 B:0%;P=0.0013)的患者出现了 T₆₀ 血清总皮质醇浓度异常(<510.4nmol/L),但无患者出现肾上腺皮质功能不全的症状。T₆₀ 总皮质醇异常或正常的患者的 T₀ 唾液皮质醇和血清游离皮质醇浓度相似。多变量分析显示,血清游离皮质醇浓度与死亡率呈正相关趋势。
在终末期肝病的肝硬化患者中,血清总皮质醇水平高估了肾上腺功能障碍的患病率。由于无法常规测量血清游离皮质醇,唾液皮质醇检测可能是一种有用的方法,但需要标准化。